Physician profile
Kapil Kumar
NPI 1972602282
$14,927.31
in general payments reported to CMS, 2019-2025
8 companies · $1,670 in 2025
The $1,670 reported for 2025 was more than what 81% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $224 · 2020: $225 · 2021: $8,965 · 2022: $82.20 · 2023: $752 · 2024: $3,010 · 2025: $1,670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,100 · Food and Beverage: $1,765 · Travel and Lodging: $1,567.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,100.00 |
| Food and Beverage | $1,765.38 |
| Travel and Lodging | $1,566.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardiologs Technologies | $8,875.00 | 2021 | |
| Abbott Laboratories | $4,547.94 | 2019-2025 | Aveir, Tacticath Ablation Catheter, Sensor Enabled, Gallant |
| Biosense Webster, INC. | $1,016.03 | 2021-2025 | Carto 3, Soundstar, Nuvision Ice Catheter |
| Boston Scientific Corporation | $200.43 | 2024 | |
| Biotronik INC. | $153.32 | 2025 | |
| Medtronic Vascular, INC. | $71.06 | 2019 | |
| Medtronic, INC. | $38.70 | 2023 | Micra |
| Organogenesis INC. | $24.83 | 2023 | Puraply |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kapil Kumar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.